Evidence map›Paper›PMID 42303628›Full record

ArticleCell death & disease2026

Pictilisib and nutrient stress synergize to induce methuosis via PI(4,5)P

Xuefei Wang, Xiaolin Sang, Yuemei Wen, Xingming Liao, Jiao Liu, Tiezheng Zheng, Tianming Xing, Min Wang, Dong An, Xining Zhang and 4 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xuefei Wang *Cancer Institute, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Xiaolin Sang *Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID http://orcid.org/0000-0001-8154-2853
Yuemei WenInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Xingming LiaoInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Jiao LiuCancer Institute, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Tiezheng ZhengCancer Institute, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Tianming XingInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Min WangCancer Institute, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Dong AnCancer Institute, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Xining ZhangCancer Institute, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Xiuling LiKey Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, China. lixiuling@dicp.ac.cn.ORCID http://orcid.org/0000-0002-6016-9516
Xinmiao LiangKey Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, China. liangxm@dicp.ac.cn.ORCID http://orcid.org/0000-0003-4394-4274
Pixu LiuZhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China. pixuliu@wmu.edu.cn.ORCID http://orcid.org/0000-0003-4094-8245
Hailing ChengCancer Institute, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China. hailing_cheng@dmu.edu.cn.ORCID http://orcid.org/0000-0001-5618-8709

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82302981National Natural Science Foundation of China (National Science Foundation of China) 82372649National Natural Science Foundation of China (National Science Foundation of China) 82472708
6 · The paper itself

Abstract

Aberrant phosphatidylinositol 3-kinase (PI3K) activation drives many cancers, but PI3K inhibitors like Pictilisib often induce cytostasis rather than cytotoxicity, limiting their therapeutic potential. Here we demonstrate that PI3K inhibition combined with nutrient stress triggers methuosis, a non-apoptotic form of programmed cell death characterized by dysregulated macropinosomes. This response occurs selectively in PI3K-aberrant cancer cells that maintain macropinocytic uptake despite PI3K inhibition. Methuosis-associated vacuoles originate from macropinosomes that retain endosomal markers but fail to undergo lysosomal fusion. Active macropinocytic uptake is essential for methuosis, as demonstrated by suppression with EIPA and Bafilomycin A1, whereas the AKT inhibitor MK2206 has no effect, establishing that direct PI3K inhibition, rather than AKT signaling, is required. Mechanistically, PI3K blockade prevents conversion of phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P

Indexed as

NeoplasmsNutrientsPhosphatidylinositol 4,5-DiphosphatePinocytosisStress, PhysiologicalAnimalsApoptosisCell Line, TumorHeterocyclic Compounds, 3-RingHumansMacrolidesMiceMice, NudePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktHeterocyclic Compounds, 3-RingMacrolidesMK 2206Phosphatidylinositol 3-KinasesPhosphatidylinositol 4,5-DiphosphatePhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-akt

Identifiers

PMID42303628
PMCPMC13500832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.